Multimodal biomedical imaging probes: development of advanced polymer nanocomposite devices for oncology (2010–2012)
Despite significant progress in cancer research worldwide, millions die yearly. Early detection and treatment gives patients the best chance of survival, however modern imaging often lacks the sensitivity for early detection while therapeutics are often poorly administered. To address these issues, this project aims to significantly advance the technology towards an integrated biomedical imaging/therapy platform for the early detection and treatment of cancer. We will gain a fundamental understanding of how polymer architecture and functionality affect device performance. The project outcomes will lead to the next generation of biomedical imaging agents with greater sensitivity and added functional modalities e.g. triggered drug delivery.